%0 Journal Article
%T BMS-933043, a Selective ¦Á7 nAChR Partial Agonist
for the Treatment of Cognitive Deficits Associated with Schizophrenia
%A Amy E. Easton
%A Bei Wang
%A Christiana Iwuagwu
%A Dalton King
%A Daniel Morgan
%A Debra Post-Munson
%A F. Christopher Zusi
%A Haiquan Fang
%A Ivar M. McDonald
%A Jim Cook
%A Jingsong Fan
%A John E. Macor
%A Kimberley A. Lentz
%A Linda J. Bristow
%A Lizbeth Gallagher
%A Matthew D. Hill
%A Nicholas J. Lodge
%A Regina Miller
%A Rex Denton
%A Richard E. Olson
%A Robert Mate
%A Robert Zaczek
%A Ronald J. Knox
%A Rulin Zhao
%A Ryan Westphal
%A Thaddeus Molski
%A Wendy Clarke
%A Yulia Benitex
%J Archive of "ACS Medicinal Chemistry Letters".
%D 2017
%R 10.1021/acsmedchemlett.7b00032
%K Schizophrenia
%K ¦Á7 neuronal nicotinic acetylcholine receptor
%K ¦Á7 nAChR partial agonist
%K quinuclidine
%K clinical candidate
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346989/